Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization ...Middle East

SEOUL, South Korea, April 18, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection. "The...

Hence then, the article about global clinical development on dengue antiviral candidate will start hyundai bioscience strives to win emergency use authorization was published today ( Friday 19/04/2024 - 06:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization )

Also on site :

• Hackers Pose as Microsoft Support to Breach Corporate Defenses .. PYMNTS.com
• Ghirardelli Recalls 13 Popular Products Over Possible Contamination
• Record Store Day NYC 2026 Report: Early Lines Across Brooklyn & Queens, Swift & Grateful Dead Top Sellers